SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001785530-23-000017
Filing Date
2023-05-11
Accepted
2023-05-11 07:07:03
Documents
64
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q howl-20230331.htm   iXBRL 10-Q 1395100
2 EX-31.1 a03312023ex311.htm EX-31.1 9636
3 EX-31.2 a03312023ex312.htm EX-31.2 9657
4 EX-32.1 a03312023ex321.htm EX-32.1 7169
  Complete submission text file 0001785530-23-000017.txt   5363690

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT howl-20230331.xsd EX-101.SCH 34887
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT howl-20230331_cal.xml EX-101.CAL 43111
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT howl-20230331_def.xml EX-101.DEF 190313
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT howl-20230331_lab.xml EX-101.LAB 440030
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT howl-20230331_pre.xml EX-101.PRE 320703
58 EXTRACTED XBRL INSTANCE DOCUMENT howl-20230331_htm.xml XML 668693
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40366 | Film No.: 23908773
SIC: 2834 Pharmaceutical Preparations